| Joy Myrlinda Quitiquit, CRNA | |
|
201 Lyons Ave, Newark, NJ 07112-2027 | |
| (973) 926-7655 | |
| Not Available |
| Full Name | Joy Myrlinda Quitiquit |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 12 Years |
| Location | 201 Lyons Ave, Newark, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306123013 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 26NO12126300 (New Jersey) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 26NJ00369200 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Newark Beth Israel Medical Center | Newark, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rwjbh Observation Associates Llc | 5193137503 | 598 |
| Garden State Healthcare Associates Llc | 8426190687 | 149 |
News Archive
The Partnership for Safe Medicines (PSM), a group of nonprofit organizations and individuals dedicated to protecting consumers from counterfeit drugs, today announced that it will convene leaders from academia, government and industry in an inaugural conference to be held October 8th at the National Press Club in Washington, D.C.
Combination treatment with everolimus, an inhibitor of the mammalian target rapamycin (mTOR), and octreotide has shown to improve progression-free survival for patients with advanced neuroendocrine tumors and a history of carcinoid syndrome, according to researchers at The University of Texas MD Anderson Cancer Center.
The AP/Houston Chronicle on Saturday examined telepharmacies - virtual pharmacy systems located in rural drug stores - in North Dakota.
Prostate cancer researchers have drawn a molecular portrait that provides the first complete picture of localized, multi-focal disease within the prostate and also unveils a new gene subgroup driving it.
How many people will die from tobacco use in developed countries in 2030?
› Verified 7 days ago
| Entity Name | Trinitas Anesthesia Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013988054 PECOS PAC ID: 1658278270 Enrollment ID: O20031212000657 |
News Archive
The Partnership for Safe Medicines (PSM), a group of nonprofit organizations and individuals dedicated to protecting consumers from counterfeit drugs, today announced that it will convene leaders from academia, government and industry in an inaugural conference to be held October 8th at the National Press Club in Washington, D.C.
Combination treatment with everolimus, an inhibitor of the mammalian target rapamycin (mTOR), and octreotide has shown to improve progression-free survival for patients with advanced neuroendocrine tumors and a history of carcinoid syndrome, according to researchers at The University of Texas MD Anderson Cancer Center.
The AP/Houston Chronicle on Saturday examined telepharmacies - virtual pharmacy systems located in rural drug stores - in North Dakota.
Prostate cancer researchers have drawn a molecular portrait that provides the first complete picture of localized, multi-focal disease within the prostate and also unveils a new gene subgroup driving it.
How many people will die from tobacco use in developed countries in 2030?
› Verified 7 days ago
| Entity Name | American Anesthesiology Of New Jersey Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386654036 PECOS PAC ID: 0042112500 Enrollment ID: O20040123001039 |
News Archive
The Partnership for Safe Medicines (PSM), a group of nonprofit organizations and individuals dedicated to protecting consumers from counterfeit drugs, today announced that it will convene leaders from academia, government and industry in an inaugural conference to be held October 8th at the National Press Club in Washington, D.C.
Combination treatment with everolimus, an inhibitor of the mammalian target rapamycin (mTOR), and octreotide has shown to improve progression-free survival for patients with advanced neuroendocrine tumors and a history of carcinoid syndrome, according to researchers at The University of Texas MD Anderson Cancer Center.
The AP/Houston Chronicle on Saturday examined telepharmacies - virtual pharmacy systems located in rural drug stores - in North Dakota.
Prostate cancer researchers have drawn a molecular portrait that provides the first complete picture of localized, multi-focal disease within the prostate and also unveils a new gene subgroup driving it.
How many people will die from tobacco use in developed countries in 2030?
› Verified 7 days ago
| Entity Name | North American Partners In Anesthesia Of New Jersey Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548433048 PECOS PAC ID: 5890867410 Enrollment ID: O20080626000318 |
News Archive
The Partnership for Safe Medicines (PSM), a group of nonprofit organizations and individuals dedicated to protecting consumers from counterfeit drugs, today announced that it will convene leaders from academia, government and industry in an inaugural conference to be held October 8th at the National Press Club in Washington, D.C.
Combination treatment with everolimus, an inhibitor of the mammalian target rapamycin (mTOR), and octreotide has shown to improve progression-free survival for patients with advanced neuroendocrine tumors and a history of carcinoid syndrome, according to researchers at The University of Texas MD Anderson Cancer Center.
The AP/Houston Chronicle on Saturday examined telepharmacies - virtual pharmacy systems located in rural drug stores - in North Dakota.
Prostate cancer researchers have drawn a molecular portrait that provides the first complete picture of localized, multi-focal disease within the prostate and also unveils a new gene subgroup driving it.
How many people will die from tobacco use in developed countries in 2030?
› Verified 7 days ago
| Entity Name | Garden State Healthcare Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700014545 PECOS PAC ID: 8426190687 Enrollment ID: O20100126000693 |
News Archive
The Partnership for Safe Medicines (PSM), a group of nonprofit organizations and individuals dedicated to protecting consumers from counterfeit drugs, today announced that it will convene leaders from academia, government and industry in an inaugural conference to be held October 8th at the National Press Club in Washington, D.C.
Combination treatment with everolimus, an inhibitor of the mammalian target rapamycin (mTOR), and octreotide has shown to improve progression-free survival for patients with advanced neuroendocrine tumors and a history of carcinoid syndrome, according to researchers at The University of Texas MD Anderson Cancer Center.
The AP/Houston Chronicle on Saturday examined telepharmacies - virtual pharmacy systems located in rural drug stores - in North Dakota.
Prostate cancer researchers have drawn a molecular portrait that provides the first complete picture of localized, multi-focal disease within the prostate and also unveils a new gene subgroup driving it.
How many people will die from tobacco use in developed countries in 2030?
› Verified 7 days ago
| Entity Name | Rwjbh Observation Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760095806 PECOS PAC ID: 5193137503 Enrollment ID: O20201209000008 |
News Archive
The Partnership for Safe Medicines (PSM), a group of nonprofit organizations and individuals dedicated to protecting consumers from counterfeit drugs, today announced that it will convene leaders from academia, government and industry in an inaugural conference to be held October 8th at the National Press Club in Washington, D.C.
Combination treatment with everolimus, an inhibitor of the mammalian target rapamycin (mTOR), and octreotide has shown to improve progression-free survival for patients with advanced neuroendocrine tumors and a history of carcinoid syndrome, according to researchers at The University of Texas MD Anderson Cancer Center.
The AP/Houston Chronicle on Saturday examined telepharmacies - virtual pharmacy systems located in rural drug stores - in North Dakota.
Prostate cancer researchers have drawn a molecular portrait that provides the first complete picture of localized, multi-focal disease within the prostate and also unveils a new gene subgroup driving it.
How many people will die from tobacco use in developed countries in 2030?
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joy Myrlinda Quitiquit, CRNA 30b Vreeland Rd, Ste 200, Florham Park, NJ 07932-1926 Ph: (973) 660-9334 | Joy Myrlinda Quitiquit, CRNA 201 Lyons Ave, Newark, NJ 07112-2027 Ph: (973) 926-7655 |
News Archive
The Partnership for Safe Medicines (PSM), a group of nonprofit organizations and individuals dedicated to protecting consumers from counterfeit drugs, today announced that it will convene leaders from academia, government and industry in an inaugural conference to be held October 8th at the National Press Club in Washington, D.C.
Combination treatment with everolimus, an inhibitor of the mammalian target rapamycin (mTOR), and octreotide has shown to improve progression-free survival for patients with advanced neuroendocrine tumors and a history of carcinoid syndrome, according to researchers at The University of Texas MD Anderson Cancer Center.
The AP/Houston Chronicle on Saturday examined telepharmacies - virtual pharmacy systems located in rural drug stores - in North Dakota.
Prostate cancer researchers have drawn a molecular portrait that provides the first complete picture of localized, multi-focal disease within the prostate and also unveils a new gene subgroup driving it.
How many people will die from tobacco use in developed countries in 2030?
› Verified 7 days ago
Emma Debenedetto, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 150 Bergen St, Newark, NJ 07103 Phone: 973-972-2513 | |
Dr. Brian Michael Jernick Jr., APN, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 201 Lyons Ave, Newark, NJ 07112 Phone: 800-843-2384 | |
Dr. Irene Goncharov, DNP Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 150 Bergen St # E245, Newark, NJ 07103 Phone: 973-972-7867 | |
Nicholas Germinario, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 201 Lyons Ave, Newark, NJ 07112 Phone: 800-843-2384 | |
Mary Caputo, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 201 Lyons Ave, Newark, NJ 07112 Phone: 973-926-7655 Fax: 973-926-3285 | |
Suzanne Lee Cottle, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 201 Lyons Ave, Newark, NJ 07112 Phone: 800-243-3839 Fax: 844-414-8291 | |
Ms. Victoria Grant, APN Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 201 Lyons Ave, Newark, NJ 07112 Phone: 973-926-7000 |